peter attia tirzepatide New insights on GLP-1 agonists—Ozempic, Wegovy, Mounjaro, and more (AMA 64 sneak peek) 398 ‒ AMA #86: GLP-1

The FDA's boxed warning for semaglutide explicitly states that the drug has been shown to cause thyroid C-cell tumors in rodent studies and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

That same study suggested that taking a GLP-1 for 1.5 years or more was associated with a 2.32 times higher chance of a deep vein thrombosis

Step 2: Online Consultation and Treatment Plan Your telehealth consultation allows you to discuss weight loss goals, medical history, and current treatments with a Klinic provider

Kidney function Kidneys help remove medications from the body

Glutathione in disease [PMID: 11122562] Laboratory literature summary: Glutathione in disease